Cargando…
SMAD4, activated by the TCR-triggered MEK/ERK signaling pathway, critically regulates CD8(+) T cell cytotoxic function
Transforming growth factor–β is well known to restrain cytotoxic T cell responses to maintain self-tolerance and to promote tumor immune evasion. In this study, we have investigated the role of SMAD4, a core component in the TGF-β signaling pathway, in CD8(+) T cells. Unexpectedly, we found that SMA...
Autores principales: | Liu, Xinwei, Hao, Jing, Wei, Peng, Zhao, Xiaohong, Lan, Qiuyan, Ni, Lu, Chen, Yongzhen, Bai, Xue, Ni, Ling, Dong, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328680/ https://www.ncbi.nlm.nih.gov/pubmed/35895826 http://dx.doi.org/10.1126/sciadv.abo4577 |
Ejemplares similares
-
Membrane repair triggered by cholesterol-dependent cytolysins is activated by mixed lineage kinases and MEK
por: Ray, Sucharit, et al.
Publicado: (2022) -
The magnitude of LFA-1/ICAM-1 forces fine-tune TCR-triggered T cell activation
por: Ma, Victor Pui-Yan, et al.
Publicado: (2022) -
TCR-engineered T cell therapy in solid tumors: State of the art and perspectives
por: Baulu, Estelle, et al.
Publicado: (2023) -
Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR
por: Manfredi, Francesco, et al.
Publicado: (2023) -
DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunity
por: Kureshi, Rakeeb, et al.
Publicado: (2023)